TP53 and prostate cancer: Gene ontology and enrichment analyses further indicated that the DEGs in PABC versus NPABC were mainly enriched in pathways in cancer, the PI3K-Akt signaling pathway, focal adhesion, the Rap1 signaling pathway, proteoglycans in cancer, microRNAs in cancer, prostate cancer, the p53 signaling pathway, small cell lung cancer, and melanoma and glioma pathways.